15th Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease :

WCIRDC Video Presentation and Poster Highlights

Award Winning Keynote Presentation

Scientific Honoree—Richard Bergman, PhD

The featured session, How They Talk: Inter-organ Communication and Diabetes Pathogenesis,1 was presented by Dr. Bergman, PdD, Alfred Jay Firestein Chair in Diabetes Research, and director of the Diabetes and Obesity Research Institute at Cedars-Sinai Medical Center in Los Angeles, California. He addressed challenges in insulin clearance, leading to type 2 diabetes (T2D), particularly as it manifests differently in at-risk subgroups such as African Americans who are the highest risk and Latinos.

Factors that known to cause T2D, including the dispositive index, the ability of beta cells to compensate for insulin resistance, insulin clearance in the liver, and glucose efficiency, which influences the ability of the body to destroy beta cells.

His work in insulin pathways has earned him the highest scientific recognition by the World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease (WCIRDC) as a leader in insulin resistance.  He elucidated pathways between organs that are responsible for influencing beta cell function.1

Gold Award Winning Abstract

By Paul J. Beisswenger, MD

Paul J. Beisswenger, MD, professor emeritus at the Geisel School of Medicine at Dartmouth University in Hanover, New Hampshire, and chief scientific officer at  PreventAGE Health Care, LLC, made a case for changing the approach to diabetes management.

"We don't yet distinguish high risk from low risk for diabetic complications, such as kidney disease and cardiovascular disease, which may be lethal," Dr. Beisswenger told EndocrineWeb, following his oral poster presentation. 

He has focused on the long silent period in which comorbid conditions may be developing in people with diabetes. To address this, he developed a predictive test to identify patients who have diabetes and are at high risk for complications so clinicians have the ability to institute treatment early, and initiate preventive strategies to improve long-term outcomes.

oxidative stress is associated with metabolic syndrome and atherogenic lipid profiles, and methionine sulfoxide levels predict cardiovascular events in both Accord and VADT subsets.

There May Be More to Shortness of Breath  

By Robert Chilton, DO

Robert Chilton, DO, FACC, associate professor of cardiology at the University of Texas Health Science Center in San Antonio, Texas, Contemporary Approach to the Management of Heart Failure with preserved function (HFpEF), When patients with diabetes experience shortness of breath, 

Dr. Chilton, an interventional cardiologist and associate professor of cardiology at the University of Texas Health Science Center, challenged that the cause of the patient's shortness of breath may not be related to body weight as is often believed; rather, the problem may result from too much volume in the heart which can be treated with medications to vastly improve how the patient feels.   

Is This the One?  New Method to Estimate Insulin Sensitivity 

By Francesca Piccinini, PhD

Dr. Piccinini, a postdoctoral scientist at Cedars-Sinai Medical Center in Los Angeles, California, introduced a more efficient method for estimating insulin sensitivity in patients with diabetes in an oral glucose tolerance test in an oral poster presentation at the World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease 2017 in Universal City, California. 

For more on this oral presentation, see the full meeting highlights at WCIRDC

Lessons Learned from Attending the World Congress

By Claude Lardinois, MD, FACP, MACN, FACE

Dr. Claude Lardinois, emeritus professor of medicine at the University of Nevada in Reno, offered key takeaways and insights gained from the sessions he attended as a   ''person on the street'' exclusive interview with EndodrineWeb.






Last updated on